Characteristics of Mycobacterium avium complex (MAC) pulmonary disease in previously treated lung cancer patients
Conclusion MAC pulmonary disease in previously treated lung cancer can occur without apparent risk factors for this NTM infection. Symptomatic improvement with MAC antimicrobial therapy appears to be lower than expected but comorbidities might influence outcomes in this patient population.
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
More News: Adenocarcinoma | Antibiotic Therapy | Cancer | Cancer & Oncology | Carcinoma | Chronic Obstructive Pulmonary | Lung Cancer | Respiratory Medicine | Skin Cancer | Squamous Cell Carcinoma | Women